Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - STOCK-BASED COMPENSATION
Stock-based Compensation EBS - Emergent BioSolutions Inc.
23.1 M
LAST VALUE
-26.19%
2 YEAR CAGR
-0.09%
5 YEAR CAGR
7.47%
10 YEAR CAGR